Estimating Dormant and Active Hematopoietic Stem Cell Kinetics through Extensive Modeling of Bromodeoxyuridine Label-Retaining Cell Dynamics

Richard C. van der Wath, Anne Wilson, Elisa Laurenti, Andreas Trumpp, Píetro LióPLoS 2009 · DOI

Abstract

Bone marrow hematopoietic stem cells (HSCs) are responsible for both lifelong daily maintenance of all blood cells and for repair after cell loss. Until recently, the cellular mechanisms by which HSCs accomplish these two very different tasks remained an open question. This study presents computational analyses supporting the existence of a dormant HSC (d-HSC) population through extensive modeling of experimental DNA label-retaining cell (LRC) data. By refining the interpretation of Bromodeoxyuridine (BrdU) dynamics, the researchers show that d-HSCs cycle only once every five to six months and comprise a much larger portion of the stem cell pool (30–45%) than previously estimated.

Introduction: The Dormancy Hypothesis

For decades, the "common dogma" in hematology was that the entire pool of hematopoietic stem cells (HSCs)—the master cells that create all blood—turned over regularly every few weeks. However, recent biological evidence suggested a "dormancy" hypothesis: that a subset of HSCs stays quiet for months, acting as a deep reserve that only wakes up during extreme stress, such as injury or chemotherapy.

Comparison of the conventional single-population HSC model versus the proposed dormancy model with two distinct populations.

The challenge lies in distinguishing true dormancy from statistical noise. Critics argued that the "long tail" of cells retaining DNA labels might just be stochastic variation within a single, uniform population. This paper sets out to prove, through rigorous mathematical modeling, that stochasticity alone cannot explain the data; a distinct dormant population must exist.

Methodology

The authors developed a multi-stage computational framework to analyze empirical BrdU label-retaining cell (LRC) datasets from mice, which included an exceptionally long chase period of up to 306 days.

  1. Deterministic and Stochastic Modeling: Systems of Ordinary Differential Equations (ODEs) were used for deterministic modeling, while a Master Equation and the Gillespie algorithm were employed to simulate the system as a Markov Process. This allowed researchers to test if the "long tail" of label retention could occur by chance in a single population.
  2. Three-Stage Refinement: The timeline was split into three biological phases: initial "uptake" (pulse), early "chase" (where BrdU acts as a stressor), and late "chase" (return to homeostasis).
  3. Detection Threshold Mapping: The model utilized a precise nonlinear mapping between cell divisions and the BrdU detection threshold (BDT), accounting for varying division requirements for label loss.

Key Insights and Results

The study's findings provide strong support for the dormancy model and offer new estimates for HSC kinetics:

  • BrdU as a Stressor: A key insight was that the labeling process itself triggers a "proliferative burst." The toxic effects of BrdU act as a minor injury, causing dormant cells to temporarily activate. Thus, d-HSCs follow a "resting-activated-resting" cycle during experiments.
  • Stochasticity is Insufficient: Stochastic simulations showed that a single population cannot retain the BrdU label as long as observed in real-world data. The two-population model achieved a Residual Sum of Squares (RSS) of 71.7, significantly better than the one-population model's RSS of 391.9.
  • The "Hidden" Majority: The model suggests that d-HSCs make up 30–45% of the total HSC pool. This is more than double the previous estimate of 15%, suggesting a much more substantial emergency reserve.
  • Turnover Rates: The analysis predicts that d-HSCs cycle once every 149–193 days, while active HSCs (a-HSCs) cycle once every 28–36 days.

Conclusion

This research confirms that the presence of a slowly dividing subpopulation of HSCs is the most likely explanation for long-term BrdU retention. Beyond theoretical confirmation, the study predicts that a 75%–92.5% purification of d-HSCs can be achieved after 59–130 days of chase. Future work will focus on identifying specific molecular markers for these dormant cells, which could have significant implications for cancer treatment and regenerative medicine by allowing researchers to manipulate these "sleeping" cells directly.

Summary updated

Abstract

Bone marrow hematopoietic stem cells (HSCs) are responsible for both lifelong daily maintenance of all blood cells and for repair after cell loss. Until recently the cellular mechanisms by which HSCs accomplish these two very different tasks remained an open question. Biological evidence has now been found for the existence of two related mouse HSC populations. First, a dormant HSC (d-HSC) population which harbors the highest self-renewal potential of all blood cells but is only induced into active self-renewal in response to hematopoietic stress. And second, an active HSC (a-HSC) subset that by and large produces the progenitors and mature cells required for maintenance of day-to-day hematopoiesis. Here we present computational analyses further supporting the d-HSC concept through extensive modeling of experimental DNA label-retaining cell (LRC) data. Our conclusion that the presence of a slowly dividing subpopulation of HSCs is the most likely explanation (amongst the various possible causes including stochastic cellular variation) of the observed long term Bromodeoxyuridine (BrdU) retention, is confirmed by the deterministic and stochastic models presented here. Moreover, modeling both HSC BrdU uptake and dilution in three stages and careful treatment of the BrdU detection sensitivity permitted improved estimates of HSC turnover rates. This analysis predicts that d-HSCs cycle about once every 149-193 days and a-HSCs about once every 28-36 days. We further predict that, using LRC assays, a 75%-92.5% purification of d-HSCs can be achieved after 59-130 days of chase. Interestingly, the d-HSC proportion is now estimated to be around 30-45% of total HSCs - more than twice that of our previous estimate.
BibTeX
@inproceedings{wath2009estimating,
  author = {Richard C. van der Wath and Anne Wilson and Elisa Laurenti and Andreas Trumpp and Píetro Lió},
  title = {{Estimating Dormant and Active Hematopoietic Stem Cell Kinetics through Extensive Modeling of Bromodeoxyuridine Label-Retaining Cell Dynamics}},
  booktitle = {PLoS},
  year = {2009},
  doi = {10.1371/journal.pone.0006972},
}
Figure